Medical Properties Trust posts $78 million Q3 net loss, authorizes $150 million buyback
Medical Properties Trust reported a third-quarter 2025 net loss of $78 million ($0.13 per share), much narrower than the $801 million loss a year earlier, while normalized funds from operations (NFFO) fell to $77 million ($0.13 per share) from $94 million ($0.16). The board also approved a stock repurchase program of up to $150 million, which the company is under no obligation to use.
Key points
- Third-quarter total revenues were $237.5 million, up from $225.8 million a year earlier.
- Third-quarter NFFO was $77 million ($0.13 per share), down from $94 million ($0.16 per share) in the 2024 period.
- The net loss includes about $82 million in impairment charges, primarily related to Prospect Medical Group bankruptcy transactions.
- On October 28, 2025, the board approved a repurchase program for up to $150 million of common stock.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:59 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 30, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.